felodipine has been researched along with Active Hyperemia in 4 studies
Felodipine: A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.
felodipine : The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We examined the effects of ARB administration on hyperinsulinemia-associated capillary density by measuring baseline skin capillary density, capillary density during reactive hyperemia (hyperemic capillary recruitment), and capillary density during venous congestion in 17 hypertensive individuals in the basal state, during a hyperinsulinemic euglycemic clamp, and during a hyperinsulinemic clamp with acute ARB administration (600 mg irbesartan), acute calcium channel blockade (CCB; 10mg felodipine ER), as a control for the reduction in blood pressure, or placebo." | 5.15 | Acute angiotensin II receptor blockade improves insulin-induced microvascular function in hypertensive individuals. ( de Leeuw, PW; Houben, AJ; Jonk, AM; Schaper, NC; Serné, EH; Smulders, YM; Stehouwer, CD, 2011) |
| "The antihypertensive and vasodilator effects of felodipine, a new calcium antagonist of the dihydropyridine group, were examined in 15 patients with moderate to severe hypertension." | 3.67 | Effect of felodipine and metoprolol on muscle and skin arteries in hypertensive patients. ( Clement, DL; De Pue, NY, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jonk, AM | 1 |
| Houben, AJ | 1 |
| Schaper, NC | 1 |
| de Leeuw, PW | 1 |
| Serné, EH | 1 |
| Smulders, YM | 1 |
| Stehouwer, CD | 1 |
| Csiki, Z | 1 |
| Garai, I | 1 |
| Shemirani, AH | 1 |
| Papp, G | 1 |
| Zsori, KS | 1 |
| Andras, C | 1 |
| Zeher, M | 1 |
| Säfholm, C | 1 |
| Havu, N | 1 |
| Clement, DL | 1 |
| De Pue, NY | 1 |
2 trials available for felodipine and Active Hyperemia
| Article | Year |
|---|---|
Acute angiotensin II receptor blockade improves insulin-induced microvascular function in hypertensive individuals.
Topics: Angiotensin Receptor Antagonists; Biphenyl Compounds; Blood Glucose; Blood Pressure; Calcium Channel | 2011 |
The effect of metoprolol alone and combined metoprolol-felodipin on the digital microcirculation of patients with primary Raynaud's syndrome.
Topics: Adult; Drug Therapy, Combination; Felodipine; Female; Fingers; Humans; Hyperemia; Hypertension; Lase | 2011 |
2 other studies available for felodipine and Active Hyperemia
| Article | Year |
|---|---|
General toxicity of the new calcium antagonist felodipine in dogs.
Topics: Adrenal Glands; Animals; Blood Cell Count; Blood Chemical Analysis; Calcium Channel Blockers; Dogs; | 1993 |
Effect of felodipine and metoprolol on muscle and skin arteries in hypertensive patients.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Felodipine; Female; Heart Rate; Humans; Hypere | 1985 |